90 related articles for article (PubMed ID: 9182329)
1. Looking for leads in HIV's battle with immune system.
Cohen J
Science; 1997 May; 276(5316):1196-7. PubMed ID: 9182329
[No Abstract] [Full Text] [Related]
2. DNA-plasmids of HIV-1 induce systemic and mucosal immune responses.
Asakura Y; Lundholm P; Kjerrström A; Benthin R; Lucht E; Fukushima J; Schwartz S; Okuda K; Wahren B; Hinkula J
Biol Chem; 1999 Mar; 380(3):375-9. PubMed ID: 10223340
[TBL] [Abstract][Full Text] [Related]
3. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
Calarota SA; Kjerrström A; Islam KB; Wahren B
Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
[TBL] [Abstract][Full Text] [Related]
4. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.
Tobery TW; Siliciano RF
J Exp Med; 1997 Mar; 185(5):909-20. PubMed ID: 9120397
[TBL] [Abstract][Full Text] [Related]
5. Cowpox Helped Against Smallpox; Will the Goat Lentivirus (Caprine Arthritis Encephalitis Virus) Help Against HIV-1?
Chebloune Y; Moussa M; Arrode-Brusés G; Gagnon J
AIDS Res Hum Retroviruses; 2015 Jun; 31(6):577-8. PubMed ID: 25844817
[No Abstract] [Full Text] [Related]
6. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.
Yang OO; Nguyen PT; Kalams SA; Dorfman T; Göttlinger HG; Stewart S; Chen IS; Threlkeld S; Walker BD
J Virol; 2002 Feb; 76(4):1626-31. PubMed ID: 11799157
[TBL] [Abstract][Full Text] [Related]
7. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
[TBL] [Abstract][Full Text] [Related]
8. Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine.
Asakura Y; Hamajima K; Fukushima J; Mohri H; Okubo T; Okuda K
Am J Hematol; 1996 Oct; 53(2):116-7. PubMed ID: 8892736
[TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
10. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
Robertson MN; Buseyne F; Schwartz O; Rivière Y
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
[TBL] [Abstract][Full Text] [Related]
11. AIDS. Escape from the immune system.
Walker BD; Goulder PJ
Nature; 2000 Sep; 407(6802):313-4. PubMed ID: 11014174
[No Abstract] [Full Text] [Related]
12. Challenges and opportunities for development of an AIDS vaccine.
Nabel GJ
Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides.
Bourgault I; Chirat F; Tartar A; Lévy JP; Guillet JG; Venet A
J Immunol; 1994 Mar; 152(5):2530-7. PubMed ID: 8133061
[TBL] [Abstract][Full Text] [Related]
15. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.
Gahéry-Ségard H; Pialoux G; Charmeteau B; Sermet S; Poncelet H; Raux M; Tartar A; Lévy JP; Gras-Masse H; Guillet JG
J Virol; 2000 Feb; 74(4):1694-703. PubMed ID: 10644339
[TBL] [Abstract][Full Text] [Related]
16. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
[TBL] [Abstract][Full Text] [Related]
17. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
da Silva J; Hughes AL
Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
[TBL] [Abstract][Full Text] [Related]
18. Vaccines based on Nef and on Nef/DeltaV2 Env.
Erfle V; Goebel FD; Guzman CA; Le Grand R
Microbes Infect; 2005 Nov; 7(14):1400-4. PubMed ID: 16243564
[TBL] [Abstract][Full Text] [Related]
19. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
20. Human immune response to HIV-1 Nef. II. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals.
Lucchiari-Hartz M; Bauer M; Niedermann G; Maier B; Meyerhans A; Elchmann K
Int Immunol; 1996 Apr; 8(4):577-84. PubMed ID: 8671645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
